We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Julie Miller

Julie J. Miller MD, PhD

Instructor, Department of Neurology, Harvard Medical School; Neuro-Oncologist, Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts

Dr. Julie Miller is an Instructor in Neurology at Harvard Medical School and a Neuro-Oncologist at the Pappas Center for Neuro-Oncology at the Massachusetts General Hospital. She received an undergraduate degree in biological engineering from Cornell University and a combined MD and PhD in Chemical and Systems Biology from Stanford University School of Medicine, where her research focused on cancer biology. She then completed Neurology residency at Massachusetts General Hospital and Brigham and Women’s Hospital through the Partners Neurology program as well as clinical fellowship in Neuro-Oncology at the Massachusetts General Hospital and Dana-Farber Cancer Institute. She has a clinical and research focus on gliomas, with a particular interest in IDH mutant gliomas, which comprise the vast majority of low-grade gliomas. Her current research program seeks to further understand IDH mutant glioma biology to uncover novel treatment strategies for this class of glioma.

Disclosures

Dr. Miller has no relevant disclosures.